News Article
Birth Beyond Borders
3 December 2020
The patchwork of regulation governing IVF treatment in Europe could be seen as a significant barrier to IVF providers looking to build pan-European brands, but these same variations are also driving a surge in cross-border treatment. Candesic partner, Marc Kitten, and analyst, Dr Nigel De Melo, discuss how consolidation in what remains a fragmented market could help drive safer and more accessible IVF services.
![](https://candesic.com/wp-content/uploads/2024/03/MK_IVFLB2020_merged-1-1_page-0002.jpg)
![](https://candesic.com/wp-content/uploads/2024/03/MK_IVFLB2020_merged-1-1_page-0003.jpg)
![](https://candesic.com/wp-content/uploads/2024/03/MK_IVFLB2020_merged-1-1_page-0004.jpg)
![](https://candesic.com/wp-content/uploads/2024/03/MK_IVFLB2020_merged-1-1_page-0005.jpg)